Further study is needed to elucidate the in vivo effect and the downstream signaling pathway through which TMEM244 functions in CTCL cells, as well as the function of its novel transcript variants. Here, TMEM244 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.